Amanita muscaria Facts
Deliriant;
Description
Fly agaric (Amanita muscaria, Amanitaceae) is a psychoactive fungus treated here as a whole-organism substance. Its primary psychoactive constituent, muscimol, is pharmacologically distinct from serotonergic psychedelics such as psilocybin. Muscimol activates GABA receptors throughout the brain, producing widespread neuronal inhibition that underlies its sedative-hallucinogenic character.[1]
Subjective effects include sedation, perceptual distortion, dreamlike imagery, euphoria, ataxia, and confusion. The experience is characteristically biphasic — initial stimulation gives way to a dreamy, sedative state as the alkaloid balance shifts — with preparation method heavily determining the character.[2]
Fatal poisoning is exceedingly rare,[3] though severe intoxications involving coma and prolonged psychosis have been documented.[4][5] Combining muscimol with alcohol, benzodiazepines, or other sedatives can compound sedation and suppress breathing to a dangerous degree.
Dose and duration
No dose or duration recorded for any route.
Body and dependence
- Acute toxicity
- Moderate
- Chronic toxicity
- Low
- Physical dependence
- Negligible
- Psychological dependence
- Low
- Withdrawal
- None recorded
- Compulsive redosing
- Low
Tolerance
- Builds
- Unknown
- Fully resets after
- Not recorded
- Carries over to
- benzodiazepines;
barbiturates; gaboxadol (THIP); other GABA-A agonists
Effectslikely at a common dose
- Perception
- Sleep-transition hallucinations;
+23 possible, including Spatial disorientation, Vestibular distortion, Visual haze / noise - Body
- Sedation;
+23 possible, including Nausea, Dizziness, Motor control impairment - Thinking
- none likely · 25 possible, including Cognitive impairment, Confusion, Memory suppression
- Feeling
- none likely · 8 possible, including Anxiety, Dysphoria, Emotional lability
- Self
- none likely · 7 possible, including Derealization, Communication suppression, Depersonalization
- Time
- none likely · 2 possible, including Temporal disorientation
- Transpersonal
- none likely · 1 possible
- Awareness
- Lucid dreaming enhancement;
+1 possible
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
Deliriants are genuinely dangerous — treat any strong reaction as a medical emergency.
- True delirium — confused, disoriented, doesn't know what's real or recognize people/danger
- Vivid, frightening hallucinations; agitation or aggression
- Hot, flushed, dry skin and high body temperature
- Dilated pupils; blurred vision
- Fast heartbeat; inability to urinate
- Seizures; unconsciousness
What to do
- Call emergency services — deliriant poisoning (especially datura / belladonna) can be life-threatening
- Keep them physically safe — they may not know what they're doing and can badly injure themselves; remove hazards and stay with them
- Do not leave them alone; do not try to reason them out of it — they are delirious
- If overheating, cool the body
- Recovery position if drowsy, vomiting, or unconscious; be ready for rescue breaths / CPR
Deliriant effects are long (many hours to more than a day) and the person is not safe or in control throughout. The main dangers are self-injury during delirium, overheating, and — for potent anticholinergics like datura — cardiac and central-nervous-system toxicity. Medical monitoring is often needed.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Okhovat A, Cruces W, Docampo-Palacios ML, Ray KP, Ramirez GA (2023) Psychoactive Isoxazoles, Muscimol, and Isoxazole Derivatives from the Amanita (Agaricomycetes) Species: Review of New Trends in Synthesis, Dosage, and Biological Properties — International Journal of Medicinal Mushrooms doi:10.1615/intjmedmushrooms.2023049458
- [2]
- [3]
- [4]^Brvar M, Mozina M, Bunc M (2006) Prolonged psychosis after Amanita muscaria ingestion — Wiener Klinische Wochenschrift PMID:16810488
- [5]^Rampolli FI, Kamler P, Carnevale Carlino C, Bedussi F (2021) The Deceptive Mushroom: Accidental Amanita muscaria Poisoning — European Journal of Case Reports in Internal Medicine doi:10.12890/2021_002212